MediGene AG Forecast, price target & analysts
MediGene AG Target price 2024 - Analyst rating & recommendation
MediGene AG Classifications & Recommendation:
MediGene AG Price Target
| Target Price | €2.00 |
| Price | €1.03 |
| Potential |
94.17%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a MediGene AG price target 2025.
The average MediGene AG target price is €2.00.
This is
94.17%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend MediGene AG to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MediGene AG stock has an average upside potential 2025 of
94.17%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million € | 6.03 | 11.00 |
| 80.70% | 82.42% | |
| EBITDA Margin | -249.25% | -111.82% |
| 711.88% | 55.14% |
1 Analyst has issued a sales forecast MediGene AG 2024 . The average MediGene AG sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast MediGene AG 2024 . The average MediGene AG EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| EV/Sales | negative |
Based on analysts' sales estimates for 2024, the MediGene AG stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
